Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CHRNA10 anticorps (C-Term)

L’anticorps Lapin Polyclonal anti-CHRNA10 a été validé pour WB et ELISA. Il convient pour détecter CHRNA10 dans des échantillons de Humain.
N° du produit ABIN7180140

Aperçu rapide pour CHRNA10 anticorps (C-Term) (ABIN7180140)

Antigène

Voir toutes CHRNA10 Anticorps
CHRNA10 (Cholinergic Receptor, Nicotinic, alpha 10 (CHRNA10))

Reactivité

  • 29
  • 12
  • 8
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 30
  • 2
Lapin

Clonalité

  • 30
  • 2
Polyclonal

Conjugué

  • 20
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp CHRNA10 est non-conjugé

Application

  • 22
  • 16
  • 13
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
Western Blotting (WB), ELISA
  • Épitope

    • 7
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term

    Fonction

    CHRNA10 Antibody

     Réactivité croisée

    Souris

    Purification

    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

    Immunogène

    Synthesized peptide derived from C-terminal of Human CHRNA10.

    Isotype

    IgG
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène

    CHRNA10 (Cholinergic Receptor, Nicotinic, alpha 10 (CHRNA10))

    Autre désignation

    CHRNA10

    Sujet

    Background: Ionotropic receptor with a probable role in the modulation of auditory stimuli. Agonist binding may induce an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. The channel is permeable to a range of divalent cations including calcium, the influx of which may activate a potassium current which hyperpolarizes the cell membrane. In the ear, this may lead to a reduction in basilar membrane motion, altering the activity of auditory nerve fibers and reducing the range of dynamic hearing. This may protect against acoustic trauma.

    Sgard F., Mol. Pharmacol. 61:150-159(2002).
    Lustig L.R., Genomics 73:272-283(2001).
    Vandenberk I., Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases.

    Aliases: Acetylcholine receptor, neuronal nicotinic, alpha-10 subunit antibody, ACH10_HUMAN antibody, Alpha 10 nAChR antibody, Cholinergic receptor nicotinic alpha 10 antibody, Cholinergic receptor, neuronal nicotinic, alpha polypeptide 10 antibody, Cholinergic receptor, nicotinic, alpha polypeptide 10 antibody, CHRNA 10 antibody, CHRNA10 antibody, NACHR alpha 10 antibody, NACHR alpha-10 antibody, NACHRA10 antibody, Neuronal acetylcholine receptor protein subunit alpha 10 antibody, Neuronal acetylcholine receptor subunit alpha-10 antibody, Nicotinic acetylcholine receptor subunit alpha 10 antibody, Nicotinic acetylcholine receptor subunit alpha-10 antibody, OTTHUMP00000013620 antibody

    UniProt

    Q9GZZ6

    Pathways

    Sensory Perception of Sound, Synaptic Membrane
Vous êtes ici:
Chat with us!